Dr. Christopher Barbieri speaks at an US TOO prostate cancer educational seminar at Weill Cornell Medicine to discuss the role of genomics in the identification and treatment of specific subtypes of prostate cancer, precision medicine tactics, as well as emerging therapies.
Feature content:
Yes
